International Travel Patterns and Health Preparations of Hematopoietic Stem Cell Transplant Recipients at Memorial Sloan-Kettering Cancer Center

Completed

• Conditions: Hematopoietic Stem Cell Transplant
• Interventions: Behavioral: questionnaire

• Registration Number: NCT01504152
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

The purpose of this study is to survey patients who underwent hematopoietic stem cell transplant (HSCT) to assess if they have traveled or not internationally after transplant. This information will help to improve the understanding of the needs for travel health strategies and interventions to provide healthy and safe travel to HSCT patients. The findings of this survey will also be used to develop travel health related interventions for patients living with cancer as well.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-12
• Study First Submitted: 2012-01-03
• Study First Submitted QC: 2012-01-04
• Study First Posted: 2012-01-05
• Status Verified: 2013-07
• Primary Completion: 2013-07
• Study Completion: 2013-07
• Last Update Submitted: 2013-07-11
• Last Update Posted: 2013-07-12

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 519

Inclusion Criteria

• Hematopoietic Stem Cell Transplant (HSCT) recipients at MSKCC from 1/1/2005 to 12/31/2010.
• Age at HSCT ≥ 18 years
• Permanent mailing address in the United States of America

Read More

Exclusion Criteria

• Subject unable to fill the questionnaire due to language barriers.

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
patients who received HSCT at MSKCC between 2005-2010	questionnaire	A self-administered patient questionnaire will be used to collect data that will assess the prevalence of international travel after HSCT and travel related morbidity and exposure risks among HSCT recipients.

Primary Outcome Measures

Name	Time	Method
prevalence of international travel	2 years	of the targeted patients Proportion of Hematopoietic Stem Cell Transplant (HSCT) patients who traveled internationally within two years after HSCT

Secondary Outcome Measures

Name	Time	Method
international travel was during a high-risk specific period	2 years	Proportion of patients traveling to destinations that are at high risk areas for infections
patients that sought pre-travel health advice	2 years	among those who traveled to high risk areas for infections
travelers that becomes ill and required medical attention	2 years	during or after return from international travel.

Trial Locations

Locations (1)

Memorial Sloan-Kettering Cancer Center; 🇺🇸 New York, New York, United States